Background: Obstructive sleep apnea syndrome (OSAS) and chronic kidney disease (CKD) are common diseases encountered in primary care. These diseases share the same pathophysiology of chronic inflammation. In recent years, it was reported that the inflammasome participates in chronic inflammation, and interleukin (IL)-18 has received significant attention as an inflammasome marker. IL-18 is also closely associated with renal function, and is a stronger predictive marker of renal function disorder than high-sensitivity C-reactive protein (hsCRP) or IL-6. OSAS is also reported to be an independent risk factor of CKD. However, other basal diseases associated with OSAS and severe renal function disorders may also be CKD risk factors, such as hypertension, diabetes mellitus, and hyperlipidemia. So it should be carefully interpreted. Therefore, we investigated renal function in OSAS patients with no potentially confounding disorders using IL-18.
Introduction
Obstructive sleep apnea syndrome (OSAS) and chronic kidney disease (CKD) are common diseases encountered in primary care. Chronic inflammation, caused by oxidative stress and endothelial cell dysfunction, represents a common pathophysiology between OSAS and CKD. Chronic inflammation has already been recognized as an important factor in cardio-renal association, whereby even a slight disorder in renal function can be a risk factor for cardiovascular disease (CVD). Chronic inflammation is closely involved in arteriosclerosis and can be identified by high-sensitivity C-reactive protein (hsCRP), which is produced by interleukin-6 (IL-6) acting on the liver. Elevated hsCRP and IL-6 are predictive markers of cardiovascular events. [1] [2] [3] In recent years, interleukin-18 (IL-18) has also been proposed as such a marker. IL-18 has a closer association with renal function, and is also a better predictive marker of renal function disorder than hsCRP or IL-6 without influence of the creatinine clearance. 4, 5 In addition, IL-18 is closely associated with chronic inflammation. In recent studies, it was reported that the inflammasome participates in chronic inflammation. On the other hand, recent studies reported increased CKD in OSAS patients. 11, 12 The findings of these studies should be carefully interpreted, since basal diseases that are easily complicated with OSAS and severe renal function disorders can be independent risk factors of CKD, including hypertension, diabetes mellitus, and hyperlipidemia.
OSAS is not only a disease to cause simple sleepiness, but also causes arteriosclerotic disease and coronary artery diseases. 13 In primary care, it has big significance to clear the association OSAS and CKD, and the cytokine senses them. This study was conducted to assess the association OSAS and renal function disorders in OSAS patient using IL-18, hsCRP and IL-6. were enrolled in this study ( When we examined each cytokine according to stage of CKD or severity of OSAS, we did not observe any significant differences across groups.
Methods

Patients free from other diseases
The background characteristics of patients free from other diseases are summarized in Figure 1 ). The only significant relationship observed was a negative correlation between IL-18 and eGFR.
Patients per complications
We compared patients according to whether or not they had complications ( Table 4 ). Levels of AHI in patients free from other diseases were significantly lower than those in patients with complications. No significant difference was observed in eGFR or cytokines.
Discussion
While complications such as basal diseases and renal function disorders were not controlled in patients of this study, there was no significant association between cytokines, including IL-18, and eGFR or AHI. These patients had basal diseases including diabetes mellitus.
Especially among patients with CKD stage G1, 45.2% Ideally, the severity of OSAS should be determined based not only on AHI score but also on levels of desaturation and clinical manifestations. Carpagnano et al showed that levels of desaturation cause oxidative stress and inflammation. 17 Thus, more research including parameters of desaturation is needed.
In addition, we found no significant differences among cytokines, renal functions, and AHI according to the presence or absence of underlying disease. The 43 patients with complications would be expected to demonstrate higher serum levels of cytokines and lower levels of eGFR. As mentioned previously, some patients' eGFR levels indicated hyperfiltration, making them unsuitable for evaluation.
Conclusions
Even when renal dysfunction was mild, chronic inflammation was present in OSAS patients. We hypothesize that IL-18 is a useful marker to detect chronic inflammation in OSAS patients and that this chronic inflammation is a factor leading to CKD. These results suggest that IL-18 is an associative marker for OSAS and renal function disorder, and may help to achieve early treatment intervention in primary care.
